comparemela.com
Home
Live Updates
Sorrento to Host Webcast to Discuss Newly Presented : compar
Sorrento to Host Webcast to Discuss Newly Presented : compar
Sorrento to Host Webcast to Discuss Newly Presented
ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), today...
Related Keywords
Georgia ,
United States ,
Philadelphia ,
Pennsylvania ,
Atlanta ,
Chris Jeffers ,
Brian Cooley ,
Russell Ross ,
Roel Querubin ,
Division Of Immunology ,
Atlanta Research Center ,
Semnur Pharmaceuticals Inc ,
Sofusa Lymphatic Drug Development ,
Head Of Sofusa Lymphatic Drug Development ,
Stanford University School Of Medicine ,
American College Of Rheumatology ,
Exchange Commission ,
Sorrento Therapeutics Inc ,
Pivotal Trialc Le Ar Program ,
Scilex Pharmaceuticals Inc ,
Marrieta Rheumatology Associates ,
Sorrento Therapeutics ,
Key Opinion Leader ,
Sofusa Lymphatic Drug Delivery System ,
American College ,
Chief Executive Officer ,
Mayflower Bioventures ,
Hibiscus Biotechnology ,
Board Certified Rheumatologist ,
Marrieta Rheumatology ,
Clinical Professor ,
Stanford University School ,
Chief Medical Officer ,
Senior Vice President ,
Sofusa Lymphatic Drug ,
Chief Technical Officer ,
Online Experiences ,
Events Calendar ,
Sofusa Business Unit ,
Private Securities Litigation Reform Act ,
Annual Report ,
Quarterly Reports ,
Investor Relations ,
Semnur Pharmaceuticals ,
Scilex Pharmaceuticals ,
All Rights ,
Nasdaq Srne ,
Nc ,